Source link : https://www.newshealth.biz/health-news/low-dose-aspirin-reduces-liver-fat-inflammation-markers/
BOSTON — Patients with metabolic-associated steatotic liver disease (MASLD, formerly NAFLD) without cirrhosis who took daily low-dose aspirin in a double-blind randomized trial demonstated significant reductions in liver fat content over 6 months compared with similar patients who took a placebo, study results show. “In MASLD without cirrhosis, low-dose aspirin, 81 milligrams daily, led to […]
Author : News Health
Publish date : 2023-11-16 18:45:52
Copyright for syndicated content belongs to the linked Source.